Wilmington, DE, United States of America

James L Meek

This inventor holds 3 USPTO granted patents. Top assignee: E.i. Dupont De Nemours and Company. Active years: 1989-1991.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 1989-1991

Loading Chart...
3 patents (USPTO):Explore Patents

Title: James L. Meek: Innovator in Phosphorylated Inositols

Introduction

James L. Meek is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of chemistry, particularly in the area of phosphorylated inositols. With a total of 3 patents to his name, Meek's work has advanced the understanding and application of these important compounds.

Latest Patents

James L. Meek's latest patents include innovative processes for regioselectively preparing phosphorylated inositols and cyclitols. His patents detail methods for creating myo-inositol 1,4,5-tris(phosphate) and myo-inositol 1,3,4,5-tetrakis(phosphate). These processes not only enhance the production of these compounds but also describe the novel cyclitols produced through these methods.

Career Highlights

Meek is currently associated with E.I. du Pont de Nemours and Company, a leading organization in the field of science and technology. His work at DuPont has allowed him to explore and develop new chemical processes that have practical applications in various industries.

Collaborations

James L. Meek has collaborated with Frank W. Hobbs, contributing to the advancement of their shared research interests. Their partnership has fostered innovation and has led to the development of new methodologies in their field.

Conclusion

James L. Meek's contributions to the field of chemistry, particularly in phosphorylated inositols, highlight his role as an influential inventor. His patents and ongoing work continue to impact the scientific community and industry practices.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…